Press release
Cardiovascular Drugs Market to Witness Robust Expansion Throughout the Forecast Period ( 2015 –2021)
Request Report for TOC @ https://www.persistencemarketresearch.com/toc/3776
Most common types of cerebrovascular disease are vascular dementia, stroke, subarachnoid hemorrhage and transient ischemic attack (TIA). Ischemic heart disease is characterized by reduced blood supply to the heart. It is one of the most common causes of death in western parts of the world. Inflammatory heart disease occurs due to the infection of bacteria and virus. This type of inflammation is often associated with episodes of rheumatic fever and kawasaki disease.
The global cardiovascular drugs market is categorized based on various anti-hypertensive drugs, anti-dyslipidemics drugs and anti-thrombotics drugs. Anti-hypertensive drug segment is further sub-segmented into Diovan/Co-Diovan, Blopress, Benicar/Benicar HCT, Micardis/Micardis HCT, Aprovel/CoAprovel, Tekturna/Rasilez, Edarbi, Cozaar/Hyzaar, Norvasc, Exforge/Exforge HCT, Coversyl and Seloken/Toprol-XL. Anti-dyslipidemics drug segment includes Lipitor, Crestor, Niaspan, TriCor/Trilipix, Zetia/Vytorin and Tredaptive. Anti-thrombotics drug segment is further sub-segmented into Plavix, Lovenox, Pradaxa, Xarelto, Brilique/Brilinta and Eliquis.
In terms of geographic, North America dominates the global cardiovascular drugs market. This is due to increased awareness about various heart diseases in the region. The U.S. represents the largest market for cardiovascular drugs followed by Canada in North America. In Europe, Germany, the U.K., Spain, Italy and France holds major share of cardiovascular drugs market. However, Asia is expected to show high growth rates in the next five years in global cardiovascular drugs market. This is due to many companies constructing their R&D facilities in the region. Less stringent wages and availability of skilled labor attracts manufacturing companies to invest in Asia. In addition, increasing awareness about heart related problems is also supporting in the growth of cardiovascular drugs market in the region. Japan, China and India are expected to be the fastest growing cardiovascular drugs markets in Asia.
In recent time, increasing prevalence of heart diseases and extensive pipeline drugs are some of the major drivers of global cardiovascular drugs market. Increasing aging population and rising number of life-style diseases are also contributing in the growth of global cardiovascular drugs market. Rising number of diabetic patients holds immense potential to the growth of global cardiovascular drugs market.
However, stringent regulations and side-effects of cardiovascular drugs hamper the growth of global cardiovascular drugs market. Moreover, patent expiry of various blockbuster drugs also obstructs the growth of the global cardiovascular drugs market. Increasing mergers and acquisitions between drug manufacturing companies and rapid product launches are key trends of the global cardiovascular drugs market.
Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/3776
Some of the major companies operating in the global cardiovascular drugs market are Bristol-Myers Squibb Company, Abbott Laboratories Inc., AstraZeneca PLC, Takeda Pharmaceutical Co. Ltd., Novartis AG, Forest Laboratories Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Daiichi Sankyo Co. Ltd., Pfizer Inc. and Solvay SA.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiovascular Drugs Market to Witness Robust Expansion Throughout the Forecast Period ( 2015 –2021) here
News-ID: 933014 • Views: …
More Releases from Persistence Market Research
Frozen Pastries Market to Reach $3.8 Bn by 2032 Driven by Convenience and Ready- …
The global frozen pastries market is set for consistent expansion over the next decade, driven by the growing demand for convenient, ready-to-bake bakery products and evolving consumer lifestyles. According to market projections, the global frozen pastries market size is likely to be valued at US$ 2.6 billion in 2025 and is estimated to reach US$ 3.8 billion by 2032, growing at a CAGR of 5.7% during the forecast period from…
Cookies Market to Reach US$ 54.4 Bn by 2032 Driven by Rising Demand for Premium …
The global cookies market is witnessing steady growth, with its valuation expected to reach US$ 38.3 billion in 2025. According to projections, the market is set to rise significantly and reach approximately US$ 54.4 billion by 2032, expanding at a compound annual growth rate (CAGR) of 5.1% between 2025 and 2032. This growth trajectory is fueled by evolving consumer lifestyles, increasing demand for convenient and on-the-go snacks, and the rising…
Flaxseeds Market Growth Driven by Health Trends | Valued at US$ 1,284.7 Mn in 20 …
The global flaxseeds market is witnessing substantial expansion, driven by the growing consumer awareness of health benefits associated with flaxseed consumption and its increasing use across diverse industries such as food and beverages, pharmaceuticals, and cosmetics. According to recent industry analysis, the global flaxseeds market size is likely to be valued at US$ 1,284.7 million in 2025, and is projected to reach US$ 2,145.3 million by 2032, expanding at a…
Sterols Market Growth: Valued at $1,268.6 Mn in 2025 to Reach $2,261.7 Mn by 203 …
The global sterols market is on a trajectory of robust expansion, anticipated to reach a valuation of US$1,268.6 million in 2025 and further grow to US$2,261.7 million by 2032, registering a healthy CAGR of 8.6% during the forecast period (2025-2032). Sterols, a group of naturally occurring compounds found in plants and animals, are gaining increasing attention across multiple industries due to their functional and health-promoting benefits. The growing global demand…
More Releases for Cardiovascular
Cardiovascular Medical Lasers: A Leading Driver Behind Rising Cardiovascular Dis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Cardiovascular Medical Lasers Industry Market Size Be by 2025?
The market size for cardiovascular medical lasers has experienced substantial growth of late. From 2024 to 2025, the market is projected to expand from $0.31 billion to $0.44 billion, with a compound annual growth rate (CAGR) of…
Rising Cardiovascular Diseases Drive Demand For Cardiovascular Medical Lasers Dr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Cardiovascular Medical Lasers Market Size By 2025?
In recent times, there has been a significant expansion in the market size of cardiovascular medical lasers. Projections indicate a surge from $0.31 billion in 2024 to $0.45 billion in 2025, reflecting a compound annual growth rate (CAGR)…
Rising Prevalence Of Cardiovascular Disorders Fuels Growth In The Cardiovascular …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Cardiovascular Devices Market Through 2025?
In recent times, there has been a significant expansion in the cardiovascular devices market size. It is expected to surge from $73.14 billion in 2024 to $79.78 billion in 2025, reflecting a compound annual growth rate (CAGR)…
Impact Of Increasing Cardiovascular Disease Patients On The Cardiovascular Infor …
The Cardiovascular Information System Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Cardiovascular Information System Market Size and Its Estimated Growth Rate?
The cardiovascular information system market has seen strong growth in recent years. It will rise from $1.16 billion in 2024…
Surge In Cardiovascular Diseases Fuels Growth Of Cardiovascular Digital Solution …
The Cardiovascular Digital Solutions Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Cardiovascular Digital Solutions Market Size During the Forecast Period?
The market size for cardiovascular digital solutions has been experiencing robust growth in the past few years. The forecast suggests it…
Cardiovascular Devices Market - Heart-Centric Innovations: Elevating Cardiovascu …
Newark, New Castle, USA: The "Cardiovascular Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiovascular Devices Market: https://www.growthplusreports.com/report/cardiovascular-devices-market/7791
This latest report researches the industry structure, sales, revenue,…
